Several specialized firms worldwide focus on the synthesis of complex pharmaceutical APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Mesylate. These compounds present significant hurdles in synthetic building due to their molecular complexity. The suppliers of these APIs often employ sophisticated methods and adhere to strict compliance s